Efficacy of Tulobuterol on human bronchial mucocillially movement using bronchoscopic specimen

Efficacy of Tulobuterol on human bronchial mucocillially movement using bronchoscopic specimen - Tulobuterol on human bronchial mucocillially movement

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017643

Enrollment

Registered

2015-05-21

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory disease requiring bronchoscopy

Interventions

Tulobuterol administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Respiratory disease requiring bronchoscopy and bronchial lavage clinically

Exclusion criteria

Exclusion criteria: serious major organ dysfunction

Design outcomes

Primary

Measure	Time frame
Activity of the movement of cilia of epithelial cells, ciliary movement frequency, and ciliary movement amplitude before and after Tulobuterol load	—

Secondary

Measure	Time frame
Difference of the effect of Tulobuterol on ciliary movement by the underlying disease	—

Countries

Japan

Contacts

Public ContactToshiyuki Sawa

Gifu Municipal Hospital Cancer Center

sawatoshiyuki@yahoo.co.jp0081-58-251-1101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026